Mark J. Mulvihill
- Molecular Biology top 10%
- Organic Chemistry top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Oncology top 10%
- Cancer Research top 10%
- Co-authors
- Marvin J. MillerElizabeth BuckQunsheng JiM. D. SurmanMaryland Rosenfeld-FranklinNeil W. GibsonAndrew CookeMatthew O’Connor
- Topics
- Growth Hormone and Insulin-like Growth Factors (13 papers)Metabolism, Diabetes, and Cancer (9 papers)PI3K/AKT/mTOR signaling in cancer (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark J. Mulvihill
46 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 863
- Organic Chemistry 536
- Endocrinology, Diabetes and Metabolism 363
- Oncology 252
- Cancer Research 214
Countries citing papers authored by Mark J. Mulvihill
This map shows the geographic impact of Mark J. Mulvihill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Mulvihill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Mulvihill more than expected).
Fields of papers citing papers by Mark J. Mulvihill
This network shows the impact of papers produced by Mark J. Mulvihill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Mulvihill. The network helps show where Mark J. Mulvihill may publish in the future.
Co-authorship network of co-authors of Mark J. Mulvihill
This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Mulvihill. A scholar is included among the top collaborators of Mark J. Mulvihill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Mulvihill. Mark J. Mulvihill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 16 | |
| 3 | 23 | |
| 4 | 5 | |
| 5 | 0 | |
| 6 | 39 | |
| 7 | 23 | |
| 8 | 13 | |
| 9 | 51 | |
| 10 | 13 | |
| 11 | 2 | |
| 12 | 164 | |
| 13 | 67 | |
| 14 | 118 | |
| 15 | Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials | 4 |
| 16 | In vivo evaluation of OSI-906, a novel small molecule kinase inhibitor of the insulin-like growth factor-1 receptor (IGF-1R) | 5 |
| 17 | 59 | |
| 18 | 72 | |
| 19 | 23 | |
| 20 | 13 |
About Mark J. Mulvihill
Mark J. Mulvihill is a scholar working on Endocrinology, Diabetes and Metabolism, Organic Chemistry and Cancer Research, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (363 citations), Organic Chemistry (536 citations) and Cancer Research (214 citations). Mark J. Mulvihill has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marvin J. Miller, Elizabeth Buck, Qunsheng Ji, M. D. Surman, Maryland Rosenfeld-Franklin, Neil W. Gibson, Andrew Cooke, Matthew O’Connor, Caroline Pirritt and Lee D. Arnold. Their work appears in journals such as The EMBO Journal, Biochemistry and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.